Anlotinib as Maintenance Therapy After First-Line Chemotherapy Combined with Consolidation Radiation for Extensive-Stage Small Cell Lung Cancer
Background Small cell lung cancer is sensitive to chemotherapy and radiotherapy, but local recurrence and distant metastasis occur shortly after treatment. This study aimed to evaluate the real-world value of anlotinib as a maintenance therapy in patients with extensive-stage small cell lung cancer...
Saved in:
Main Authors: | Jinbo Ma MD, Xiaoyan Ma MS, Wei Zhang MD, Shanliang Hu MS, Rukun Zang MS, Xiaolong Wu MS, Jie Song MD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Technology in Cancer Research & Treatment |
Online Access: | https://doi.org/10.1177/15330338251317571 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Safety of Anlotinib and PD-1/L1 Inhibitors as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer Patients who Have Achieved Stable-Disease After First-Line Treatment with Chemotherapy and Immunotherapy: A Retrospective Study
by: Yi Peng MD, et al.
Published: (2025-01-01) -
Association of Hospital Consolidation with Cancer Outcomes
by: Justin Graff MD, et al.
Published: (2025-01-01) -
Surgery for Patients With cT3/4N2M0, Stage IIIB NSCLC. Is It Time to Redefine Resectability?
by: J. Humberto Rodriguez-Quintero, MD, MPH, et al.
Published: (2025-01-01) -
Identifying Patient Characteristics Associated With Opioid Use to Inform Surgical Pain Management
by: Anish K. Agarwal, MD, MPH, MS, et al.
Published: (2023-12-01) -
A case of eruptive keratoacanthomas and lichen planus secondary to nivolumab treatment for stage IV melanoma
by: Daniel S. Alicea, MS, et al.
Published: (2025-03-01)